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Nicotine is the major addictive substance in cigarettes. Nicotinic acetylcholine receptors (nAChRs)
are thought to play an important role in nicotine addiction of smokers. One of the genes, a-4 sub-
unit of nicotinic acetylcholine receptor (CHRNA4) gene was reported to be associated with smok-
ing behavior in many populations.
Aim: The aim of this study is to determine association between a-4 subunit of nicotinic acetyl-
choline receptor single nucleotide polymorphism (rs2236196 and rs2273502 loci) and smoking
behavior among Malay Males.
Methods: The study was conducted in Malay smokers (n= 248) and non-smoking controls
(n= 248). DNA was extracted from leucocytes and the two SNPs were determined by a polymerase
chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The PCR product
was digested with restriction enzymes AfeI and Sau96I, respectively.
Results and conclusion: We found that the AA genotype frequency for CHRNA4 rs2236196
polymorphism in the smoker group was 80.6% while in nonsmoker 77.0%. No mutation (GG geno-
type) was detected in both groups. The AG genotype for the smoker group was 19.4% while in the
nonsmoker group 23.0%. There was no significant difference observed in the genotype (v2 = 5.106,
p= 0.078) and allele frequencies between both study groups. On the other hand, no mutation of
CHRNA4 rs2273502 (TT genotype) was detected in the non-smoker group while the frequencies
of genotype CC and heterozygous CT in non-smokers were 75.8% and 24.2%, respectively. In
the smoker group, the frequencies were 73.4%, 2.0% and 24.6%, for TT, CC and CT, respectively.
There was no significant difference observed in rs2273502 (v2 = 5.16, p= 0.078) and smoking
72 A.B. Ruzilawati et al.behavior of the subjects. In conclusion, the results revealed that CHRNA4 rs2273502 and rs2236196
gene polymorphisms are not statistically significantly associated with smoking behavior in our pop-
ulation.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Smoking behavior is influenced by both genetic and environ-
mental factors. Previous studies have shown that genetic
factors strongly influence smoking behavior and nicotine
addiction [1].
According to Arinami et al. [2] the genetic predisposition to
smoking is determined by multiple genes. A variety of genes
have been investigated for their association with smoking
behavior, including loci involving dopamine receptors and
transporters [3–6], serotonin receptors and transporters
[7–10], nicotinic acetylcholine receptors (nAChRs) [11–13],
tyrosine hydroxylase [14], tryptophan hydroxylase [15],
monoamine oxidase [16], catechol-O-methyltransferase [17],
adrenergic receptors [18], l opioid receptors [19] and cannabi-
noid receptors [20]. Among all, nicotinic acetylcholine receptor
(nAChRs) genes were selected as our main interest of
investigation.
Nicotine is the major addictive substance in cigarettes.
Nicotine exerts its pharmacological and physiological effects
by binding to nAChRs [11]. Molecular analyses have identi-
fied the expression of nine a-subunits (a2 – a10) of nAChRs
in the central nervous system [21]. According to Tapper
et al. [22] a-4 subunit of nicotinic acetylcholine receptor
(CHRNA4) is the most important for nicotine-induced
reward, tolerance, as well as sensitization. The CHRNA4
gene, which was mapped to chromosome 20q13.2–13.3 is
17 kb long and contains six exons [23]. Therefore, the gene
encoding this subunit can be considered as a good candidate
gene for smoking behavior.
The rs2273502 locus is sited in the 30-downstream region
of intron 2 of the CHRNA4 gene, close to the transcription
initiation site of exon 3. Li and colleague [12] reported
association of CHRNA4 rs2273502 with nicotine dependence.
This can be an important functional regulatory element for
the expression of exon 3 of the CHRNA4 gene. The
CHRNA4 rs2236196 gene was also reported to be associated
with nicotine dependence or smoking behavior in many pop-
ulations [12,13]. The gene was characterized by an A? G
transition located in the 30-untranslated region of CHRNA4
[11].
However, there has been no prior study reported for these
two genes in Malay Males, so far. Considering the evidence
for ethnic differences in nicotine metabolism in response to
smoking and in the genetic influences on nicotine dependence
[24–27], we were interested to investigate the association of
CHRNA4 (rs2236196 and rs2273502) genes with smoking
behavior among Malay male smokers in Kelantan, Malaysia.
Therefore, the objective of this study was to determine the fre-
quency of single nucleotide polymorphisms in the CHRNA4
(rs2236196 and rs2273502) genes among Malay male smokers
in Kelantan, Malaysia.2. Methods and materials
2.1. Subjects and methods
The study protocol was approved by the Ethics Committee
of School of Medical Sciences, Universiti Sains Malaysia,
Malaysia. The work has been carried out in accordance with
The Code of Ethics of The World Medical Association
(Declaration of Helsinki) for experiments in human. Most of
the subjects were recruited from two institutions of higher edu-
cation which were IPG Pengkalan Chepa, Kelantan, Malaysia
(College for teacher education) and Universiti Sains Malaysia,
Health Campus, Kelantan, Malaysia and some from various
locations in Kota Bharu, Kelantan, Malaysia. Subjects were
informed about the experimental procedures and study aim
before written informed consents were obtained. Blood sam-
ples were obtained from 496 Malay Males, aged 18–50 years
old who agreed to participate in the study. The subjects were
categorized as smokers (n= 248) and non-smokers
(n= 248). Ex-smokers or those who had stopped smoking
prior to the study were excluded. Other exclusion criteria
included a history of cancer, coronary heart disease, liver dis-
ease and undergoing treatment for drug addiction.
To be included in the study, smokers were defined as having
smoked more than 100 cigarettes in a lifetime and being a cur-
rent smoker at the time of the study. Non-smokers were
defined as volunteers who never smoked cigarettes. Smoking
behavior was assessed with a questionnaire concerning tobacco
use. The questions included age of smoking initiation, number
of cigarettes smoked daily, factors influencing smoking and
number of quit attempts. The subjects in the smoker group
were then classified based on the scores that they get from
the validated Malay version of Fagerstrom Test for Nicotine
Dependence (FTND-M) [28]. The six-questions of FTND-M
are the valid self-reporting measure of nicotine dependence
and can assist physicians in determining appropriate cessation
treatment. All subjects were scored into five levels of catego-
rizations which were very low nicotine dependence (0–2), low
nicotine dependence (3–4), moderate nicotine dependence (5),
high nicotine dependence (6–7) and very high nicotine depen-
dence (8–10).2.2. DNA extractions
Three milliliters of venous blood was drawn into a sterile tube
containing EDTA and stored at 20 C until the isolation of
genomic DNA. Genomic DNA was isolated from 300 ll of
blood using QIAamp DNA Blood Mini Kit (QIAGEN, Hil-
den). The purity of the DNA and their concentrations were
measured by spectrophotometry, Biophotometer Uvette
(Eppendorf, Germany) at 280 nm absorbance.
Table 1 Primer sequences used in PCR-RFLP of CHRNA4 rs2236196 and rs2273502.
Primers Sequence Size of PCR product (bp) Endo-nuclease
rs2236196
Forward 50-AGCTCCACAAAACTCTGTTC-30 326 AfeI
Reverse 50-AGTCTCTCAGCAGATCTG-30
rs2273502
Forward 50-TCACCTGCTTCACCCATACG-30 237 Sau96I
Reverse 50-TCCCCTCAGAGTCCCCATCC-30
Figure 1 Schematic representation of RFLP analysis of CHRNA4 rs2236196 gene. In the mutant type, AfeI cleaves a 326 bp fragment
into 126 and 200 bp whereas the wild type is not cleaved.
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For the analysis of CHRNA4 gene rs2236196 polymorphism,
genomic DNA was PCR-amplified in a final volume of 25 ll
containing 2.5 ll of 10 PCR buffer with KCl (Vivantis,
Malaysia), 0.2 lM/L of each primer as listed in
Table 1, 0.2 lmol/l of dNTP (Vivantis, Malaysia), 1.5 mmol/l
MgCl2 and 2.5U Taq DNA polymerase (Vivantis, Malaysia).
The following PCR conditions were used: an initial denatura-
tion step for 3 min at 95 C, followed by 25 cycles of 1 min at
95 C, 30 s at 55 C and 1 min at 72 C with a 10 min final
extension at 72 C. Fig. 1 shows schematic representations of
RFLP analysis of CHRNA4 rs2236196. A 326 bp fragment
was yielded by running on a 1% agarose gel (Fig. 2a) in the
presence of ethidium bromide. The PCR product was digestedwith 1U restriction enzyme AfeI (Vivantis, Malaysia) for 2 h at
37 C. Digestion of the PCR product with AfeI resulted in
326 bp fragments for homozygous wild type (wt) sequence
and 3 fragments of 326, 200 and 124 bp for heterozygous wild
type – mutant (wt/mt) allele (Fig. 2b).
2.4. Genotyping of CHRNA4 rs2273502 gene using PCR-RFLP
The PCR reaction was carried out in a total volume of 25 ll
consisting of 2.5 ll of 10 PCR Buffer with KCl (Fermentas),
0.4 lM of each primer (Table 1), 500 lmol/L dNTP mixture,
3.75 mM MgCl2 and 0.5U Taq DNA polymerase. PCR ampli-
fication was performed with an initial denaturation at 94 C
for 5 min and then 35 cycles of 94 C for 30 s, 59 C for
30 C s and 72 C for 1 min, and then held at 72 C for
(a)
(b)      1     2         3       4           5 
100bp
300bp
200bp
326bp
200bp
100bp
200bp
300bp
326bp
126bp
Figure 2 (a) PCR products for CHRNA4 rs2236196. (b) RFLP
results for heterozygous wild type-mutant (lanes 2, 4) (126, 200
and 326 bp) and homozygous wild type (lane 2) after digestion
with AfeI.
(a)
1     2     3    4     5     6     7(b)
237 bp
500 bp
200 bp
100 bp
136 bp150 bp
50 bp
72 bp
165 bp
Figure 3 (a) PCR products for CHRNA4 rs2273502 primers. (b)
RFLP results for homozygous wild type (lanes 2, 5, 6, 7),
heterozygous wild type-mutant (lane 3) and homozygous mutant
(lane 4) after digestion with Sau96.
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observed (Fig. 3a). One unit of restriction enzyme, Sau96I
(New England Biolabs, MA, USA) was used to digest the
5 ll PCR product for 1 h at 37 C. The digestion products werethen resolved on a 1.4% agarose gel containing EtBr and were
visualized under UV light. Samples with homozygous
wild-type sequences show two bands of 72 and 136 bp. The
homozygous mutant sequence was digested into 72 and
165 bp while heterozygous wild type mutant gave 72, 136
and 165 bp (Fig. 3b).
2.5. Direct DNA sequencing
Upon successful PCR, three samples from each different geno-
type were chosen at random and sent for sequencing. PCR
products were purified using MEGAquick PCR purification
kit (Intron, Kyeonggi-do, Korea) and were sent for DNA
sequencing. The sequencing processes were performed by using
Applied Biosystem 3730 XL Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA). The sequencing results
were verified against the published sequence for CHRNA4
(rs2236196 and rs2273502). (GenBank accession number:
NT_011333).
2.6. Statistical analysis
Sample size was calculated using Power and Sample Size Cal-
culation Software (PS Software ver.2.1.31), where alpha (a)
was set at 0.05 with 80% power. All statistics in this study were
performed using the SPSS package (ver. 20, SPSS, Chicago,
IL). All values for demographic parameters were expressed
as mean ± SD. The ages of the subjects were compared using
Mann–Whitney tests. Independent-samples T-test was used to
compare the differences in height, weight and BMI of the
subjects.
Data were compiled according to the genotypes and allele
frequencies. The 95% confidence intervals were calculated
for all observed allele frequencies. The allele and genotype
frequencies were calculated to equilibrium using a
Hardy–Weinberg equation (p2 + 2pq + q2 = 1). We used
non-parametric chi-square test to assess the significance of
allele frequency and genotype distribution with smoking
behavior among the subjects. A p< 0.05 was considered sta-
tistically significant.
3. Results and discussion
In all reactions, correct lengths of expected PCR products were
obtained. The restriction enzyme used in the present study was
found have worked successfully as depicted in Figs. 2b and 3b.
The presence of mutations in CHRNA4 (rs2236196 and
rs2273502) gene polymorphisms was confirmed by DNA
sequencing. The electropherogram sequence of wild-type and
polymorphic mutant of CHRNA4 rs2273502 is shown in
Fig. 4. A homozygous C to T transition was observed in the
sense strand of the polymorphic variant.
From our findings, there were significant differences in
mean age between smokers and non-smokers (Table 2). No
significant differences were found in height, weight and BMI
between smoker and non-smoker groups.
The genotypes and allelic frequencies of the polymorphism
CHRNA4 rs2236196 in nonsmoker and smoker groups are
shown in Table 3. The allele frequencies and genotype distribu-
tion of this gene in each group satisfied the Hardy–Weinberg
equilibrium law. From the results, the AA genotype frequency
Figure 4 Direct sequencing results for CHRNA4 rs2273502. The circle represents base substitution C? T (a) An electropherogram
sequence of wild type CHRNA4 rs2273502 and (b) an electropherogram sequence of polymorphic mutant of CHRNA4 rs2273502.
Table 2 Demographic characterization of subjects.
Non-smokers
(n= 248)
Smokers
(n= 248)
p-Value
Mean (SD) Mean (SD)
Age (years)a 24.0 (16.0)c 33.5 (19.0)c 0.000
Height (m)b 168.6 (0.06) 168.0 (0.06) 0.307
Weight (kg)b 69.58 (12.32) 69.24 (12.45) 0.760
Body mass index
(kg/m2)b
24.47 (4.16) 24.50 (4.05) 0.945
a Mann–Whitney test.
b Independent-samples T-test.
c Median (IQR).
Table 3 Genotypic and allelic distribution and statistical
analyses of nAchR rs 2236196 polymorphisms in smoker and
nonsmoker groups.
Nonsmoker n (%) Smoker n (%) v2 (p)
Genotype
AA 191 (77.0) 200 (80.6) 0.979 (0.323)
GG 0 (0.0) 0 (0.0)
AG 57 (23.0) 48 (19.4)
Allele
A 439 (88.5) 448 (90.32) 0.863 (0.353)
G 57 (11.5) 48 (9.7)
Table 4 Genotypic and allelic distribution and statistical
analyses of nAchR rs2273502 polymorphisms in smoker and
nonsmoker groups.
Nonsmoker n (%) Smoker n (%) v2 (p)
Genotype
CC 182 (73.4) 188 (75.8) 5.106 (0.078)
TT 5 (2.0) 0 (0.0)
CT 61 (24.6) 60 (24.2)
Allele
C 425 (85.7) 436 (87.9) 1.064 (0.302)
T 71 (14.3) 60 (12.1)
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No mutation (GG genotype) was detected in both groups.
The AG genotype for the smoker group was 19.4% while in
the nonsmoker group was 23.0%. No significant differenceswere observed in the genotype (v2 = 5.106, p= 0.078) and
allele frequencies between both study groups.
The genotypes and allelic frequencies of the polymorphism
CHRNA4 rs2273502 in nonsmoker and smoker groups are
shown in Table 4. The allele frequencies and genotype distribu-
tion of this gene in each group satisfied the Hardy–Weinberg
equilibrium law. No significant differences were observed in
the genotype (v2 = 5.16, p= 0.078) and smoking status of
the subjects.
No association was observed between the FTND-M score
and the genotypes of the CHRNA4 rs2236196 (Table 5) and
CHRNA4 rs2237502 (Table 6).
The SNPs of rs2273502 and rs2236196 were chosen in
this study due to the significant association with smoking
behavior that has been reported by other studies. However,
the results indicated that the genotypes and allelic frequen-
cies of CHRNA4 (rs2236196 and rs2273502) gene polymor-
phisms were not significantly associated with smoking
behavior.
Table 5 Association of nAchR rs2236196 genotype with
FTND-M score.
FTND-M score rs2236196
genotypes, n (%)
AA AG X2 (p)
0–2 (very low nicotine
dependence)
104
(52.0)
24
(50.0)
2.284
(0.684)
3–4 (low nicotine dependence) 40 (20.0) 8 (16.7)
5 (moderate nicotine
dependence)
22 (11.0) 9 (18.8)
6–7 (high nicotine dependence) 23 (11.5) 5 (10.4)
8–10 (very high nicotine
dependence)
11 (5.5) 2 (4.2)
Table 6 Association of nAchR rs2273502 genotype with
FTND-M score.
FTND-M score rs2273502
Genotypes, n (%)
CC CT X2 (p)
0–2 (very low nicotine
dependence)
102 (54.3) 26 (43.3) 6.92
(0.140)
3–4 (low nicotine dependence) 30 (26.0) 18 (30.0)
5 (moderate nicotine
dependence)
25 (13.3) 6 (10.0)
6–7 (high nicotine dependence) 20 (10.6) 8 (13.3)
8–10 (very high nicotine
dependence)
11 (5.9) 2 (3.3)
76 A.B. Ruzilawati et al.Our results contrast with a number of other studies that
have successfully shown relationships between CHRNA4 vari-
ants and smoking-related variables. Feng et al., [11] were the
first to report significant associations of single CHRNA4 SNPs
and also of a multilocus CHRNA4 haplotype, with susceptibil-
ity to nicotine addiction in Chinese men. They studied six
single-nucleotide polymorphisms (SNPs) residing in the
CHRNA4 gene (rs1044396, rs1044397, rs2273504, rs2273502,
rs3827020 andrs2236196) with respect to nicotine dependence.
They recruited 621 male subjects with multiple nicotine-
addicted siblings. They used FTND [29] to identify families
affected by nicotine addiction. Their analyses for CHRNA4
demonstrated a significant association of the haplotypes
formed with both nicotine addiction (v2 = 19.19, p< 0.001)
and the age-adjusted FTND score (v2 = 19.19, p< 0.001).
Another association of single nucleotide polymorphisms
(SNPs) in CHRNA4 gene is observed in European-American
or African-American population [12]. The study tested six
SNPs in the CHRNA4 gene for association with nicotine
dependence. Nicotine dependence was determined using smok-
ing quantity, the heaviness of smoking index and the Fager-
strom test. They recruited 2037 subjects from 602 families of
either European-American or African-American ancestry in
the USA. Analysis of the six SNPs within CHRNA4 of
European-American sample demonstrated that the SNPs
rs2273504 and rs1044396 are significantly associated with the
adjusted smoking quantity and FTND score, respectively.
In the African-American samples, SNPs rs3787137 and
rs2236196 are each significantly associated with at least twoadjusted nicotine dependence measures. Association of
rs2236196 with the adjusted heaviness of the smoking index
and FTND scores in the African-American samples remained
significant after correction for multiple testing. SNP rs2236196
showed a significant association in African American samples
but showed no association in the European-American sample
group. Their findings provide convincing evidence for the
involvement of the CHRNA4 subunit in nicotine addiction.
Several analyses have been carried out on CHRNA4
rs2236196. This SNP has been reported to have an association
with nicotine dependence and smoking behavior in African
American women [30]. They have also identified that mutation
in this gene was associated with subjective responses to smok-
ing. In their study, participants were asked to smoke a cigar-
ette after an 8 h abstinence period and they were rated on
the effects of smoking phenotypes, including the physical, cog-
nitive, and rewarding properties of smoking. They found par-
ticipants with a heterozygous genotype at SNP rs2236196
exhibited an increased sensitivity to all 4 subjective measures
of smoking. A study in 5500 German subjects has also
observed a significant association between rs2236196 and
smoking-related phenotypes [13].
The general lack of an association between the SNPs tested
in our study and smoking related behavior is in agreement with
many other studies [31–33]. No association between rs2236196
and smoking status was found by Spruell et al. [33]. However,
they found a weak association of rs2273502 with smoking
abstinence. A study done by Etter et al. [32] also found no
association of SNP at rs2236196 in CHRNA4 with smoking
status or other smoking related variables among smokers in
Switzerland.4. Conclusion
In conclusion, the present study is the first to provide evidence
for the association of allelic variants of CHRNA4 rs2273502
and rs2236196 with smoking behavior in the Malay Male pop-
ulation. However, the results revealed that CHRNA4
rs2273502 and rs2236196 gene polymorphisms are not signifi-
cantly associated with smoking behavior in our population.
The study of the association between genetics and smoking
behavior is complex and is dependent on many factors, making
the association unique to each population.Acknowledgements
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